|
Real-time Estimate
Cboe BZX
20:12:20 15/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.935 USD | -2.73% |
|
-6.91% | +120.27% |
| 09-11 | Agenus Inc. - Shareholder/Analyst Call | |
| 09-10 | Agenus Inc. Presents Three-Year Overall Survival Data for Botensilimab Plus Balstilimab in Recurrent Ovarian Cancer | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AGEN | Delayed | |
CBOE
| AGEN | Real-time | |
|
Tradegate
| AJ8 | Real-time | |
|
Deutsche Boerse AG
| AJ8 | Delayed | |
|
Boerse Muenchen
| AJ8 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 8.36 | 8.36 | 8.24 |
| Spread/Res. | -17.27% | -17.27% | -16.06% |
| Spread/Supp. | +1.27% | +39.17% | +44.40% |
| Support | 6.83 | 4.97 | 4.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AGEN Stock
- Charts Agenus Inc.
Select your edition
All financial news and data tailored to specific country editions
